These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6481710

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The triphasics: insights for effective clinical use.
    Youngkin EQ, Miller LG.
    Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 7. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB.
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [Abstract] [Full Text] [Related]

  • 8. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR.
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [Abstract] [Full Text] [Related]

  • 9. The interaction between St John's wort and an oral contraceptive.
    Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC.
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [Abstract] [Full Text] [Related]

  • 10. [Pros and cons of triphasic oral contraception].
    Berdah J.
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [Abstract] [Full Text] [Related]

  • 11. A clinical overview of a new triphasic contraceptive containing gestodene.
    Christie T.
    Int J Fertil; 1989 Sep; 34 Suppl():40-9. PubMed ID: 2576257
    [Abstract] [Full Text] [Related]

  • 12. [Triella: a French multicenter double blind clinical study].
    Castaigne JP.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
    [Abstract] [Full Text] [Related]

  • 13. [The triphasic pill].
    Belaisch J.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):368-72. PubMed ID: 12280209
    [Abstract] [Full Text] [Related]

  • 14. Initial selection of oral contraceptives.
    Reiter SL, Baer LJ.
    J Reprod Med; 1990 May; 35(5):547-8. PubMed ID: 2352250
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J.
    Int J Fertil; 1991 May; 36 Suppl 1():25-31. PubMed ID: 1678378
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and biological justifications for the use of Triella].
    McGuire JL, Pasquale SA, Castaigne JP.
    Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
    [Abstract] [Full Text] [Related]

  • 17. Clinical use of biphasic and triphasic pills.
    Cohen J.
    IPPF Med Bull; 1985 Aug; 19(4):1-2. PubMed ID: 12280230
    [Abstract] [Full Text] [Related]

  • 18. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Aug; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 19. Rationale for a new triphasic oral contraceptive.
    Pasquale SA.
    Int J Fertil; 1986 Aug; 31 SU [UPDATE]():13-9. PubMed ID: 2899554
    [Abstract] [Full Text] [Related]

  • 20. Current perspectives on combination oral contraceptives.
    Smith MA, Youngkin EQ.
    Clin Pharm; 1984 Aug; 3(5):485-96. PubMed ID: 6386284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.